{"id":370,"date":"2019-10-03T12:00:23","date_gmt":"2019-10-03T12:00:23","guid":{"rendered":"http:\/\/rare2020.www.bioevents.net\/?page_id=370"},"modified":"2021-07-15T11:16:03","modified_gmt":"2021-07-15T11:16:03","slug":"welcome-letter","status":"publish","type":"page","link":"https:\/\/lymphoma2022.com\/welcome-letter\/","title":{"rendered":"Welcome Letter"},"content":{"rendered":"<p>Dear Colleagues,<\/p>\n<p>It is our great pleasure to welcome you to the <strong>Lymphoma 2022 Virtual Conference: State-of-the-Art and Future Directions<\/strong> which will take place <strong>February 24th, 2022<\/strong>.<\/p>\n<p>The aims of this conference are to present a state-of-the-art update on etiology and genomics of lymphoma, to discuss novel therapies recently approved or currently evaluated for lymphoma treatments and to summarize the current knowledge and future directions in treatment of most common lymphomas. The lectures will be presented by international lymphoma experts.<\/p>\n<p>This Conference will welcome hematologists, healthcare clinicians, hematologic oncologists, medical, radiation and surgical oncologists, physicians, oncology nurses, nurse practitioners, occupational therapists, researchers, pharmacists and other healthcare professionals working in the fields of oncology and hematology.<\/p>\n<p>The Conference will focus on the following key areas:<br \/>\n. Genomics of lymphoma<br \/>\n. Novel therapies in lymphoma, including Car-T, bispecific antibodies, ADCs and NK Cars<br \/>\n. Current treatment paradigms of most common lymphomas and ongoing clinical trials<\/p>\n<p>Share your research by submitting an abstract for e-poster presentation. Join us as a Sponsor or Exhibitor and benefit from maximum visibility and exposure to a broader audience.<\/p>\n<p>We look forward to seeing you at <strong>Lymphoma 2022 Virtual Conference: State-of-the-Art and Future Directions<\/strong>.<\/p>\n<p>Sincerely,<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-1838\" src=\"https:\/\/www.bioevents.net\/lymphoma2022\/wp-content\/uploads\/sites\/66\/2021\/07\/Izidore-Lossos_Photo.jpg\" alt=\"\" width=\"135\" height=\"155\" \/><\/p>\n<p><strong>Izidore S. Lossos M.D.<\/strong><br \/>\n<em>Conference Chair<\/em><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dear Colleagues, It is our great pleasure to welcome you to the Lymphoma 2022 Virtual Conference: State-of-the-Art and Future Directions which will take place February 24th, 2022. The aims of this conference are to present a state-of-the-art update on etiology and genomics of lymphoma, to discuss novel therapies recently approved or currently evaluated for lymphoma [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-370","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Welcome Letter - Lymphoma2022<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lymphoma2022.com\/welcome-letter\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Welcome Letter - Lymphoma2022\" \/>\n<meta property=\"og:description\" content=\"Dear Colleagues, It is our great pleasure to welcome you to the Lymphoma 2022 Virtual Conference: State-of-the-Art and Future Directions which will take place February 24th, 2022. The aims of this conference are to present a state-of-the-art update on etiology and genomics of lymphoma, to discuss novel therapies recently approved or currently evaluated for lymphoma [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lymphoma2022.com\/welcome-letter\/\" \/>\n<meta property=\"og:site_name\" content=\"Lymphoma2022\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-15T11:16:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bioevents.net\/lymphoma2022\/wp-content\/uploads\/sites\/66\/2021\/07\/Izidore-Lossos_Photo.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lymphoma2022.com\/welcome-letter\/\",\"url\":\"https:\/\/lymphoma2022.com\/welcome-letter\/\",\"name\":\"Welcome Letter - Lymphoma2022\",\"isPartOf\":{\"@id\":\"https:\/\/lymphoma2022.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/lymphoma2022.com\/welcome-letter\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/lymphoma2022.com\/welcome-letter\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.bioevents.net\/lymphoma2022\/wp-content\/uploads\/sites\/66\/2021\/07\/Izidore-Lossos_Photo.jpg\",\"datePublished\":\"2019-10-03T12:00:23+00:00\",\"dateModified\":\"2021-07-15T11:16:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/lymphoma2022.com\/welcome-letter\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lymphoma2022.com\/welcome-letter\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lymphoma2022.com\/welcome-letter\/#primaryimage\",\"url\":\"https:\/\/www.bioevents.net\/lymphoma2022\/wp-content\/uploads\/sites\/66\/2021\/07\/Izidore-Lossos_Photo.jpg\",\"contentUrl\":\"https:\/\/www.bioevents.net\/lymphoma2022\/wp-content\/uploads\/sites\/66\/2021\/07\/Izidore-Lossos_Photo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lymphoma2022.com\/welcome-letter\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/lymphoma2022.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Welcome Letter\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lymphoma2022.com\/#website\",\"url\":\"https:\/\/lymphoma2022.com\/\",\"name\":\"Lymphoma2022\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/lymphoma2022.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lymphoma2022.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/lymphoma2022.com\/#organization\",\"name\":\"Lymphoma2022\",\"url\":\"https:\/\/lymphoma2022.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lymphoma2022.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/lymphoma2022.com\/wp-content\/uploads\/sites\/66\/2021\/07\/cropped-Lymphoma-2022-logo-1.png\",\"contentUrl\":\"https:\/\/lymphoma2022.com\/wp-content\/uploads\/sites\/66\/2021\/07\/cropped-Lymphoma-2022-logo-1.png\",\"width\":149,\"height\":149,\"caption\":\"Lymphoma2022\"},\"image\":{\"@id\":\"https:\/\/lymphoma2022.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Welcome Letter - Lymphoma2022","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lymphoma2022.com\/welcome-letter\/","og_locale":"en_US","og_type":"article","og_title":"Welcome Letter - Lymphoma2022","og_description":"Dear Colleagues, It is our great pleasure to welcome you to the Lymphoma 2022 Virtual Conference: State-of-the-Art and Future Directions which will take place February 24th, 2022. The aims of this conference are to present a state-of-the-art update on etiology and genomics of lymphoma, to discuss novel therapies recently approved or currently evaluated for lymphoma [&hellip;]","og_url":"https:\/\/lymphoma2022.com\/welcome-letter\/","og_site_name":"Lymphoma2022","article_modified_time":"2021-07-15T11:16:03+00:00","og_image":[{"url":"https:\/\/www.bioevents.net\/lymphoma2022\/wp-content\/uploads\/sites\/66\/2021\/07\/Izidore-Lossos_Photo.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/lymphoma2022.com\/welcome-letter\/","url":"https:\/\/lymphoma2022.com\/welcome-letter\/","name":"Welcome Letter - Lymphoma2022","isPartOf":{"@id":"https:\/\/lymphoma2022.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lymphoma2022.com\/welcome-letter\/#primaryimage"},"image":{"@id":"https:\/\/lymphoma2022.com\/welcome-letter\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bioevents.net\/lymphoma2022\/wp-content\/uploads\/sites\/66\/2021\/07\/Izidore-Lossos_Photo.jpg","datePublished":"2019-10-03T12:00:23+00:00","dateModified":"2021-07-15T11:16:03+00:00","breadcrumb":{"@id":"https:\/\/lymphoma2022.com\/welcome-letter\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lymphoma2022.com\/welcome-letter\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lymphoma2022.com\/welcome-letter\/#primaryimage","url":"https:\/\/www.bioevents.net\/lymphoma2022\/wp-content\/uploads\/sites\/66\/2021\/07\/Izidore-Lossos_Photo.jpg","contentUrl":"https:\/\/www.bioevents.net\/lymphoma2022\/wp-content\/uploads\/sites\/66\/2021\/07\/Izidore-Lossos_Photo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/lymphoma2022.com\/welcome-letter\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lymphoma2022.com\/"},{"@type":"ListItem","position":2,"name":"Welcome Letter"}]},{"@type":"WebSite","@id":"https:\/\/lymphoma2022.com\/#website","url":"https:\/\/lymphoma2022.com\/","name":"Lymphoma2022","description":"","publisher":{"@id":"https:\/\/lymphoma2022.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lymphoma2022.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/lymphoma2022.com\/#organization","name":"Lymphoma2022","url":"https:\/\/lymphoma2022.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lymphoma2022.com\/#\/schema\/logo\/image\/","url":"https:\/\/lymphoma2022.com\/wp-content\/uploads\/sites\/66\/2021\/07\/cropped-Lymphoma-2022-logo-1.png","contentUrl":"https:\/\/lymphoma2022.com\/wp-content\/uploads\/sites\/66\/2021\/07\/cropped-Lymphoma-2022-logo-1.png","width":149,"height":149,"caption":"Lymphoma2022"},"image":{"@id":"https:\/\/lymphoma2022.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/lymphoma2022.com\/wp-json\/wp\/v2\/pages\/370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lymphoma2022.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/lymphoma2022.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/lymphoma2022.com\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/lymphoma2022.com\/wp-json\/wp\/v2\/comments?post=370"}],"version-history":[{"count":65,"href":"https:\/\/lymphoma2022.com\/wp-json\/wp\/v2\/pages\/370\/revisions"}],"predecessor-version":[{"id":1929,"href":"https:\/\/lymphoma2022.com\/wp-json\/wp\/v2\/pages\/370\/revisions\/1929"}],"wp:attachment":[{"href":"https:\/\/lymphoma2022.com\/wp-json\/wp\/v2\/media?parent=370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}